Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma

Human Pathology

Volumn 38, Issue 11, 2007, Pages 1621-1627

  Berg, Jan P ^a   Zhou, Qi ^a   Breuhahn, Kai ^b   Schirmacher, Peter ^b   Patil, Mohini A ^c   Chen, Xin ^c   Schäfer, Nico ^a   Höller, Tobias T ^a   Fischer, Hans Peter ^a   Büttner, Reinhard ^a   Gütgemann, Ines ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hepatocellular carcinoma; Immunohistochemistry; Jab1; p27Kip1

Indexed keywords

BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN JAB 1; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PATHOGENESIS; PROTEIN EXPRESSION;

CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; LIVER; LIVER NEOPLASMS; PEPTIDE HYDROLASES;

EID: 35348824895     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.03.007     Document Type: Article

References (29)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Patil M.A., Gutgemann I., Zhang J., et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 26 (2005) 2050-2057
3. Claret F.X., Hibi M., Dhut S., Toda T., and Karin M. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383 (1996) 453-457
4. Tomoda K., Yoneda-Kato N., Fukumoto A., Yamanaka S., and Kato J.Y. Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem 279 (2004) 43013-43018
5. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9 (1995) 1149-1163
6. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
7. Toyoshima H., and Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 (1994) 67-74
8. Tomoda K., Kubota Y., Arata Y., et al. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J Biol Chem 277 (2002) 2302-2310
9. Tomoda K., Kubota Y., and Kato J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398 (1999) 160-165
10. Carrano A.C., Eytan E., Hershko A., and Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1 (1999) 193-199
11. Ivan D., Diwan A.H., Esteva F.J., and Prieto V.G. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions. Mod Pathol 17 (2004) 811-818
12. Rassidakis G.Z., Claret F.X., Lai R., et al. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Clin Cancer Res 9 (2003) 1121-1128
13. Esteva F.J., Sahin A.A., Rassidakis G.Z., et al. Jun activation domain binding protein 1 expression is associated with low p27(Kip1) levels in node-negative breast cancer. Clin Cancer Res 9 (2003) 5652-5659
14. Ito Y., Yoshida H., Nakamura Y., et al. Expression of Jun activation domain-binding protein 1 and p27 (Kip1) in thyroid medullary carcinoma. Pathology 37 (2005) 216-219
15. Goto A., Niki T., Moriyama S., et al. Immunohistochemical study of Skp2 and Jab1, two key molecules in the degradation of P27, in lung adenocarcinoma. Pathol Int 54 (2004) 675-681
16. Sui L., Dong Y., Ohno M., et al. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 7 (2001) 4130-4135
17. Kallioniemi O.P., Wagner U., Kononen J., and Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 10 (2001) 657-662
18. Terminology of nodular hepatocellular lesions. International Working Party. Hepatology 22 (1995) 983-993
19. Fiorentino M., Altimari A., D'Errico A., et al. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res 6 (2000) 3966-3972
20. Emberley E.D., Niu Y., Leygue E., et al. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 63 (2003) 1954-1961
21. Kouvaraki M.A., Rassidakis G.Z., Tian L., Kumar R., Kittas C., and Claret F.X. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res 63 (2003) 2977-2981
22. Ito Y., Yoshida H., Matsuzuka F., et al. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Anticancer Res 23 (2003) 4121-4125
23. Dong Y., Sui L., Watanabe Y., Yamaguchi F., Hatano N., and Tokuda M. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Clin Cancer Res 11 (2005) 259-266
24. Ito Y., Matsuura N., Sakon M., et al. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Hepatology 30 (1999) 90-99
25. Fiorentino M., Altimari A., Ravaioli M., et al. Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. Clin Cancer Res 10 (2004) 1789-1795
26. Tannapfel A., Grund D., Katalinic A., et al. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer 89 (2000) 350-355
27. Armengol C., Boix L., Bachs O., et al. p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma. J Hepatol 38 (2003) 591-597
28. Nan K.J., Jing Z., and Gong L. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27Kip1 in hepatocellular carcinoma. World J Gastroenterol 10 (2004) 1425-1430
29. Jing Z., Nan K.J., and Hu M.L. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma. World J Gastroenterol 11 (2005) 1910-1916